Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer. [electronic resource]
Producer: 20140918Description: 1308-16 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- mortality
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Large Cell -- mortality
- Carcinoma, Non-Small-Cell Lung -- mortality
- Carcinoma, Squamous Cell -- mortality
- Chemoradiotherapy
- Cisplatin -- administration & dosage
- Female
- Follow-Up Studies
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Neoplasm Staging
- Pemetrexed
- Prognosis
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.